Desay Battery Unveils Innovative Energy Storage Solutions at SNEC PV+ Expo, Announces Strategic Partnership with Turkish Energy Leader Demir Enerji Français
HUIZHOU, China, June 12, 2025 /CNW/ -- Desay Battery, a global leader in energy storage innovations, achieved a key milestone at the 2025 SNEC PV+ Expo, by announcing a strategic partnership with Demir Enerji, Turkey's leading energy company. Both parties are committed to collaborating on several energy storage projects in Ukraine, including the MHP Chicken Block Solar + ESS 2.5MW/5MWh project, MHP Project #1 with a capacity of 2MW/5MWh and Project #2 with 20MW/40MWh, as well as the VOLTAGEG project with 10MW/40MWh.
"Through our partnership with Demir Enerji, we are excited to bring our most advanced energy storage technologies to Turkey's dynamic energy market," said Vice-President Jack Guo of Desay Battery. "This collaboration is a significant step in our global expansion strategy and highlights our dedication to advancing the transition to clean energy globally."
At the exhibition, Desay Battery showcased cutting-edge battery cell technology, featuring a diverse range of products. This lineup included high-performance lithium-ion cells (DLP-100, DLP-280, DLP-314) as well as the innovative DSP-60 sodium-ion battery. In addition to cell technology, Desay Battery unveiled its modular energy storage systems, which consist of scalable lithium modules at 100Ah and 280Ah, along with 52S battery packs that allow for flexible integration. For commercial and industrial applications, the company introduced the Lumos energy storage cabinets with capacities of 215kWh and 344kWh. For residential use, offerings included the 10-25kWh LV Residential ESS and the 21kWh HV DCDC Residential ESS (280Ah), designed to provide efficient and space-saving solutions for homes. Furthermore, Desay Battery exhibited large-scale infrastructure solutions, including the Vita 5MWh Utility ESS liquid-cooled container storage system, which supports grid stability, as well as UPS battery cabinets designed for critical backup power.
The products showcased not only highlight Desay Battery's leadership in energy storage technology but also demonstrate the company's deep understanding of diverse application needs, along with its ability to deliver precise, tailored solutions.
"With over 20 years of specialized experience, Desay Battery has firmly positioned itself as a Tier 1 energy storage provider, recently earning a spot on BloombergNEF's Energy Storage Tier 1 List for Q2 2025. This recognition underscores the company's vertically integrated approach, which covers the entire spectrum from cell development to complete system integration. Supported by state-of-the-art manufacturing facilities and rigorous quality control processes, Desay Battery continues to set the standard in the energy storage industry."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Canada News.Net
9 hours ago
- Canada News.Net
Fat loss, not strength loss: inside pharma's latest race
WASHINGTON, D.C.: As the global weight-loss market explodes, drugmakers are now racing to solve a less visible problem: protecting muscle mass. Existing treatments like Novo Nordisk's Wegovy and Eli Lilly's Zepbound have proven effective at helping people shed pounds, but not all the weight lost is fat. Muscle loss, especially in older patients, can raise the risk of falls and lower physical strength, spurring a wave of new drug development. Here's a look at the key players and their experimental therapies designed to combat fat while preserving or even boosting lean muscle: Eli Lilly Lilly spent nearly $2 billion in 2023 to acquire Versanis Bio's bimagrumab, a treatment that inhibits the myostatin protein to help protect muscle. The company is testing the drug alone and with Novo's Wegovy in a mid-stage trial. It also partnered with China's Laekna to develop a similar drug. Regeneron Regeneron is evaluating trevogrumab—a similar myostatin-targeting antibody—in combination with Wegovy and another drug, garetosmab. The three-part study includes both healthy and obese participants and tracks changes in weight, fat, waist size, body composition, and thigh muscle volume. It is expected to wrap up next year. Scholar Rock Scholar Rock's apitegromab, also a myostatin inhibitor, is being tested with Lilly's Zepbound. A mid-stage study showed the combination helped preserve more lean mass than Zepbound alone. Roche Roche is studying RG6237, an anti-latent myostatin, in overweight individuals. Starting this year, it plans to combine this drug with its own GLP-1 candidate, CT-388, in a mid-stage trial. Biohaven Biohaven's taldefgrobep alfa recently fell short in treating spinal muscular atrophy, but in an early-stage obesity trial, it reduced fat mass and increased lean mass and bone density. A mid-stage obesity trial is planned. Keros Pharma Keros' KER-065 targets both myostatin and activin A. In preclinical trials, it boosted lean mass and cut fat in obese mice. A first-stage trial in obese men is underway, with results expected in Q1 2025. Northstrive Biosciences Northstrive, formerly Elevai Labs, bought two myostatin-targeting drugs (EL-22 and EL-32) from South Korea's MOA Life Plus. It plans to seek FDA clearance for human trials this year, paired with GLP-1 therapies. Veru Veru's oral drug enobosarm targets androgen hormones. In a mid-stage study, patients who took it with Wegovy lost 71 percent less muscle than those on Wegovy plus a placebo. A late-stage study will now assess stair climb power in patients 60 and older. 35 Pharma 35Pharma will soon begin early-stage testing of HS235, which targets activin and GDF ligands involved in muscle, bone, and blood metabolism. Data is expected in the second half of 2025. Arrowhead Pharmaceuticals Arrowhead is developing two RNA-based obesity drugs—ARO-INHBE and ARO-ALK7—that interrupt fat-storage signals. Human trials of ARO-INHBE, both solo and alongside Lilly's tripeptide, are planned for this year. Six Peaks / AstraZeneca In May 2024, AstraZeneca agreed to pay up to $80 million to Swiss biotech SixPeaks Bio for access to an antibody targeting activin cell receptors. The goal was to protect the muscle during weight loss and potentially acquire SixPeaks down the line.
Japan Forward
9 hours ago
- Japan Forward
Will Expo 2025 Give the Kinki Region the Boost It Needs?
このページを 日本語 で読む Despite the ongoing 2025 Osaka-Kansai Expo, the Kinki region continues to struggle with weak economic sentiment. This was underscored in the Cabinet Office's May Economy Watchers Survey. In contrast, Okinawa Prefecture, where the theme park JUNGLIA OKINAWA is set to open on July 25, currently boasts the highest economic sentiment in the country. With roughly four months left until the Expo concludes, can the Kinki region close the gap and overcome this regional disparity? The Economy Watchers Survey is a monthly questionnaire that asks respondents whether they feel the economy is "good" or "bad." It was introduced in 2000 by Taichi Sakaiya, a novelist from Osaka. Sakaiya played a key role in the 1970 World Expo during his tenure as Secretary of the Economic Planning Agency, which is now the Cabinet Office. The results, compiled for Japan as a whole and also by twelve regions, are referred to as the streetcorner economy. They are used to gauge the "gut feelings" of people who closely observe economic trends. A new route connecting the East and West Gates opens at the Osaka-Kansai Expo, allowing visitors to walk between them in Konohana Ward, Osaka City. Approximately 2,000 individuals participate in the survey each month. They include taxi drivers, retail store owners, small and medium-sized business operators, as well as employees of department stores, supermarkets, and restaurants. Their perceptions of the economy compared to three months ago are measured by a Diffusion Index called Current Economic Conditions. A score above 50 indicates that the economy is improving. In May, the Current Economic Conditions Index for the entire country rose to 44.4, a 1.8-point bump from the previous month. That marked the first improvement in five months. Of the 12 regions, 11 saw a rise, while the Chubu region was the only area to decline, dropping by 2.3 points. The Kinki region saw a slight increase of 0.8 points in May compared to April, reaching 45.1. However, among the 11 regions showing positive sentiment, it recorded the smallest change. Since February, the Kinki region index has stayed below 50. That is the threshold that separates boom from bust. Meanwhile, the Osaka-Kansai Expo opened on April 13. While it was expected to provide a boost, its effect on the economic outlook has been minimal. "The Expo's impact is insufficient at the moment," says Masayuki Sato, a researcher at the NLI Research Institute. Osaka-Kansai Expo opening night at Yumeshima, Konohana Ward, Osaka City, April 13. The pavilions are being illuminated, accompanied by a spectacular fireworks display. (©Kotaro Hikono) Nevertheless, in the May survey, some observers did note encouraging signs from the Expo. Still, its reach is limited, and many people have not yet experienced it, which may help explain the lack of widespread enthusiasm across the Kinki region. One respondent, for instance, noted that although the Expo mascot is popular and stores at Shinkansen stops and terminal stations are performing well, "other stations are not benefiting as much." This suggests that the positive impact may be limited to specific transportation hubs. Another respondent said, "The large number of charter buses used for the Expo has made it difficult to reserve buses, leading to a decline in group visits to other leisure facilities." There are also concerns that the Expo is drawing customers away from other tourist destinations in the Kinki region, dampening overall excitement in the area. By juxtaposition, Okinawa has consistently outperformed the Kinki region over the past six months. In both April and May, it recorded positive growth for two consecutive months compared to the previous months. Sato at the NLI believes there are several contributing factors. For example, easing concerns over Trump tariffs, a rebound in inbound tourism, and high expectations for Junglia Okinawa, a planned development in northern Okinawa. Junglia is a nature-based theme park scheduled to open near the World Natural Heritage Site of Yanbaru. Built around the concept of "Power Vacance!," it blends expansive forests with cutting-edge technology. The park offers over 20 attractions, including encounters with lifelike dinosaur robots in the forest and scenic rides in large balloons. Additionally, visitors can enjoy a variety of restaurants and shops. The park's total area is approximately 60 hectares, or about 13 times the size of Tokyo Dome. In the May survey, there were no mentions of Junglia Okinawa in the Current Economic Conditions Index. However, it appeared frequently in the Future Economic Conditions Index, which reflects expectations for the next two to three months. For example, one respondent in the survey noted: "In addition to the expected demand for tourism during the summer vacation period, the opening of a large leisure facility is likely to slightly boost the economy in the next two to three months." Bird's-eye view rendering of Junglia, set to open in Okinawa in 2025. (Provided by Japan Entertainment) Another comment said: "The opening of the large leisure facility is expected to draw more attention to Okinawa and increase the number of tourists." Sato believes that the rising expectations reflected in the Future Economic Conditions Index are beginning to influence the Current Economic Conditions Index. Aside from its appealing attractions, Okinawa's smaller geographic size compared to the Kinki region allows a large theme park to have a more noticeable impact. The benefits of the Expo have yet to be fully felt across the Kinki region. With the busy summer vacation season approaching, there is an urgent need to channel visitor interest beyond the Expo venue but also toward the region's many existing attractions. Author: Nobuhiko Yamaguchi このページを 日本語 で読む
Cision Canada
a day ago
- Cision Canada
Media Advisory - Simultaneous launch of Canadian space technologies Français
LONGUEUIL, QC, June 21, 2025 /CNW/ - Several technologies funded by the Canadian Space Agency under the Space Technology Development Program will be launched into space by SpaceX. These projects are a testament to Canada's leadership in space innovation. EarthDaily Analytics will use high-precision thermal imagers to monitor plant transpiration. The data collected could help farmers make decisions about irrigation, fertilization and crop rotation. It could also provide precise information about areas at greatest risk of wildfires, in order to protect our communities. INO provided infrared cameras as part of this project. Galaxia will launch its first satellite, MÖBIUS-1, a software-defined satellite designed to carry various types of Earth observation sensors. The MÖBIUS constellation could be used for a variety of applications, such as defence, environmental monitoring, agriculture, infrastructure, maritime operations and transportation. GHGSat will add two satellites to its commercial constellation, bringing the company's total to 13 methane detection satellites and one CO 2 detection satellite. Mission Control will test its onboard artificial intelligence (AI) software and machine learning operations system SpacefarerAI™ in partnership with Spire Global. Their Persistence mission aims to show how AI can analyze satellite images directly in space, thereby eliminating the need to send all data to Earth for processing. Xona Space Systems will test Pulsar, a demonstration satellite designed to validate a new generation of satellite navigation from low Earth orbit. This technology could improve precision and reliability of positioning services, including in urban areas, remote areas and the Arctic. Also contributing to the GHGSat and EarthDaily Analytics satellites are ABB 's business unit in Quebec, supplying sophisticated optical sensors, and Xiphos Systems, providing high-performance onboard processors. These innovations demonstrate the ability of Canadian companies to develop innovative technologies that meet the needs of the space program and have strong commercial potential. Media who wish to speak with a Canadian Space Agency expert or a representative from one of these Canadian companies are asked to contact the Media Relations Office.
